Comments on: Comparative effectiveness research

By: Caroline

Caroline — Thu, 19 Nov 2009 21:46:34 +0000

I thought you might be interested in "sitting in on" a panel discussion on CER that was held last week in Baltimore. there's a video of the meeting here:

http://speakhealth.org/are-there-changes-ahead-for-the-science-of-medicine/

Feel free to pass it along to colleagues who may be interested, and by all means leave your thoughts.
~c

By: Nick Berry

Nick Berry — Mon, 02 Mar 2009 11:16:08 +0000

The idea of CER is great, but why must the taxpayers pay for it. Especially of comparing privately researched treatments. I understand the need for government funded research. If you in the medical field want to study something do so with your own private dollars. Not mine. It’s benefiting not only the patients, but the bottom lines of private industry.

By: We need comparative effectiveness research, or, I agree with Paul Krugman for the first time ever | Telecom News

Thu, 19 Feb 2009 04:13:07 +0000

[...] Cross, Robert Centor, and Bob Doherty offer their take on the [...]

By: Ann Weaver Hart

Ann Weaver Hart — Mon, 16 Feb 2009 15:55:23 +0000

Please let your representatives and senators in Washington know that you support CER. It is a logical and reasonable approach and it is badly needed.

By: Jeffrey A. Tkac

Jeffrey A. Tkac — Mon, 16 Feb 2009 02:22:16 +0000

Perhaps a CER program is “long overdue”, but adding it to a bill supposedly written as a emergency stimulus measure is underhanded and deceitful. How long will it take this research to bear fruit that benefits the economy????

By: Bruce Kaler M.D.

Bruce Kaler M.D. — Sat, 14 Feb 2009 07:25:23 +0000

CER clearly provides more useful information for both patients and health care providers. The pharmaceutical industry has rarely done head to head studies unless they could upstage a competitor. Unfortunately due to the fortunes required to bring a product to market the process has been skewed much by profits. Too often we see review of a new medication offers no advantage over existing available treatments, other than providing market share for the newest manufacturer joining the field.
As a physician, anything that can provide guidence to the most practical and cost effective treatment is welcomed. CER is long overdue.

By: Jim Breiling

Jim Breiling — Sat, 14 Feb 2009 02:30:32 +0000

Might one (preferably more) of the medical professional associations affirm or reaffirm their support for such a program of evaluations and for evidence-based medicine as the best way to provide effective and cost-efficient care?

By: Jim Breiling

Jim Breiling — Sat, 14 Feb 2009 02:27:00 +0000

Bravo! Well said!

By: Dr. Bob (FP)

Dr. Bob (FP) — Fri, 13 Feb 2009 23:04:40 +0000

This is exactly the kind of thing we need.

What’s better for an osteoporis patient in my office? Actonel, Vit D, or an exercise program?

Is there really any benefit of Altace over Lisinopril?

What would be better for mild cognitive impairment? Aricept, exercise, or placebo?

Should I add Byetta, Januvia, Actos, or insulin when metformin isn’t enough?

I’m sure the drug companies will lobby against in many subtle ways, but American medicine badly needs CER.